Moreover, in a murine model, the downregulation of the group VII of PLA2 genes improves inflammation and reduces the burden of atherosclerosis [151], suggesting Lp-PLA2 as a potential target for therapeutics. This evidence concerns the gene PLA2G7 and atherosclerosis.